Arthritis

Description

Arthritis refers to pain, swelling and or redness in the joints of the body. There are over 100 different forms of arthritis and it is often a feature of a wide range of infectious and autoimmune diseases. In the early stages of arthritis, lab tests, including antibody tests, are often used as a guide to an earlier and accurate diagnosis.

Mitogen offers a number of autoimmune and immune biomarker tests to aid in the diagnosis of arthritis.  Notably, Mitogen’s Arthritis Test Panel includes two rheumatoid factor (RF) antigens and four distinct citrullinated peptides (CCP).  Conventional anti-citrullinated protein autoantibody (ACPA) or anti-cyclic citrullinated peptide (CCP) testing generates approximately 10-15% false-negative results for patients suffering from rheumatoid arthritis (RA).  Mitogen’s comprehensive Arthritis Panel addresses these missed diagnoses with a much broader spectrum of CCP antigens.  The Arthritis Test Panel has led to significant improvements in sensitivity for diagnosing rheumatoid arthritis over conventional ACPA testing.

With the availability of this test, clinicians should avoid the costs and loss-of-time that inherent with early generations of CCP testing.  By solely ordering this panel for suspected RA and known RA patients you gain an increased chance in early detection and missing fewer diagnostic opportunities.